Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility.
Fitzgerald LM et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 2013